| Pts IC | Pts ADV | Place | Nég | % | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| max | min | moy | min | max | moy | min | max | moy | min | max | moy | max | min | moy | 12 | 6 | 9.64 | 0 | 3 | 1.29 | 1 | 7 | 3 | -92 | -212 | -162 | 90.13 | 76.4 | 82.51 |
| Tour | Match | Score | Plc | IC | ADV | Top | Pts | % | ic | adv | plc | nég | % | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 | SRMa-PHEb | 46.0-32.0 | 1 | 12.0 | 0.0 | 932 | -92 | 90.13 | x | x | x | x | x | |||||
| 4 | ASSb-PHEb | 39.0-39.0 | 7 | 6.0 | 3.0 | 904 | -158 | 82.52 | x | x | x | |||||||
| 5 | PHEb-CRQa | 50.0-28.0 | 2 | 11.0 | 0.0 | 946 | -175 | 81.50 | x | |||||||||
| 6 | PHEb-KIHb | 41.0-37.0 | 1 | 12.0 | 0.0 | 834 | -99 | 88.13 | x | x | x | |||||||
| 8 | PHEb-SRMa | 28.0-50.0 | 4 | 8.5 | 3.0 | 1026 | -194 | 81.09 | x | |||||||||
| 9 | PHEb-ASSb | 39.0-39.0 | 5 | 8.0 | 2.0 | 839 | -198 | 76.40 | x | |||||||||
| 10 | CRQa-PHEb | 34.0-44.0 | 3 | 10.0 | 1.0 | 969 | -212 | 78.12 | x | |||||||||